Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Profit After Tax (2013 - 2026)

Scynexis' (SCYX) quarterly Profit After Tax came in at $7.4 million in Q2 2026, up 207.44% on a YoY basis from $2.4 million in Q2 2025, and up 134.73% quarter-over-quarter from -$21.3 million in Q1 2026.

Analysis

Scynexis (SCYX) Profit After Tax (2013 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Profit After Tax for 14 consecutive years, with $7.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Profit After Tax rose 207.44% year-over-year to $7.4 million; the trailing twelve-month figure through Jun 2026 stood at -$10.2 million (up 47.56% YoY), and the FY2025 full-year result was -$8.6 million, up 59.56% from the prior year.
  • Profit After Tax climbed to $7.4 million in Q2 2026 per SCYX's latest filing, from -$21.3 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $122.3 million in Q2 2023 and bottomed at -$33.9 million in Q1 2023.
  • Historically, Profit After Tax has averaged -$2.2 million across 5 years, with a median of -$6.2 million in 2022.
  • The sharpest annual moves came in 2022 and 2023: Profit After Tax slumped 4789.92% in 2022, then jumped 1016.15% in 2023.
  • Over 5 years, Profit After Tax stood at -$14.4 million in 2022, then tumbled by 35.74% to -$19.6 million in 2023, then surged by 77.37% to -$4.4 million in 2024, then surged by 376.52% to $12.3 million in 2025, then sank by 39.66% to $7.4 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered $7.4 million, -$21.3 million, and $12.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 2.38 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -10.50 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 1.10 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 1.30 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 472.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -782.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 164.49 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 97.50 Mn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -290.61 Mn
10 Scynexis 58.41 Mn -56.29 Mn - 7.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.40 Mn
Mar 31, 2026 -21.30 Mn
Dec 31, 2025 12.26 Mn
Sep 30, 2025 -8.59 Mn
Jun 30, 2025 -6.89 Mn
Mar 31, 2025 -5.39 Mn
Dec 31, 2024 -4.43 Mn
Sep 30, 2024 -2.81 Mn
Jun 30, 2024 -14.46 Mn
Mar 31, 2024 411,000.00
Dec 31, 2023 -19.59 Mn
Sep 30, 2023 -1.76 Mn
Jun 30, 2023 122.26 Mn
Mar 31, 2023 -33.88 Mn
Dec 31, 2022 -14.43 Mn
Sep 30, 2022 -29.58 Mn
Jun 30, 2022 -13.35 Mn
Mar 31, 2022 -5.45 Mn
Dec 31, 2021 -29.28 Mn
Sep 30, 2021 -605,000.00